Below are the most recent publications written about "Interferon-gamma" by people in Profiles.
-
Pham LK, Cervantes MM, Lim PN, Dubey D, Tufts A, Mitchell MC, Shinkawa T, Behar SM, Rothchild AC. NRF2-mediated inhibition of alveolar macrophage MHC II expression during Mycobacterium tuberculosis infection. Cell Rep. 2026 Jun 23; 45(6):117397.
-
Costa CM, Almeida GG, Lindestam Arlehamn CS, Queiroz-Glauss CP, Gunderman VHG, Pereira MMM, Amaral LRD, Pereira DB, Tada MS, Martins-Filho OA, Gazzinelli RT, Antonelli LRDV. Different clinical forms of Plasmodium vivax infection result in unique T cell epitope-specific immune responses. J Immunol. 2026 Apr 15; 215(4).
-
Sharma P, Sharma RD, Sarkar B, Panwar V, Das M, Singh LV, Jain N, Chaturvedi S, Mehra L, Rathee A, Sharma S, Foo S, Lee A, N PK, Das P, Viswanathan V, Kornfeld H, Howland SW, Babu S, Nandicoori VK, Singhal A, Kumar D. Ly6G+ granulocytes-derived IL-17 limits protective host responses and promotes tuberculosis pathogenesis. Elife. 2026 Feb 05; 13.
-
Vargas-Robles D, Yap YR, Singha B, Tien J, Purandare M, Rojas-Correa M, Madziar C, Picker M, Dumont T, Leftwich HK, Frisard CF, Ward DV, Peter I, Olendzki B, Maldonado-Contreras A. Association of vaginal IL-4, IL-6, IL-8, IL-17, IFN-?, and dietary intake with IBD status and vaginal microbiota in pregnant individuals. PLoS One. 2026; 21(1):e0335178.
-
de Souza Silva L, Monks BG, Forconi CS, Crabtree JN, De Paula Tamburro N, Kurt-Jones EA, Gazzinelli RT, Fitzgerald KA, Golenbock DT. Interleukin-10 limits immune-mediated pathology in chronic subclinical plasmodial infection. PLoS Negl Trop Dis. 2025 Sep; 19(9):e0013554.
-
Shinkawa T, Chang E, Rakib T, Cavallo K, Lai R, Behar SM. CD226 identifies effector CD8+ T cells during tuberculosis and costimulates recognition of Mycobacterium tuberculosis-infected macrophages. Cell Rep. 2025 Sep 23; 44(9):116184.
-
Oliveira LVN, Hargarten JC, Wang R, Carlson D, Park YD, Specht CA, Williamson PR, Levitz SM. Peripheral blood CD4+ and CD8+ T cell responses to Cryptococcus candidate vaccine antigens in human subjects with and without cryptococcosis. J Infect. 2025 Jul; 91(1):106521.
-
Proulx MK, Wiggins CD, Reames CJ, Wu C, Kiritsy MC, Xu P, Gallant JC, Grace PS, Fenderson BA, Smith CM, Lindestam Arlehamn CS, Alter G, Lauffenburger DA, Sassetti CM. Noncanonical T cell responses are associated with protection from tuberculosis in mice and humans. J Exp Med. 2025 Jul 07; 222(7).
-
Almeida GG, Costa CM, Costa PAC, Gomes GR, Figueiredo MM, Torres KJ, de Carvalho AF, Valiate BVS, Sampaio JR, Carvalho BC, Pereira DB, Martines A, Tada MS, Soares IS, Ponmattam J, Castro MC, Golenbock DT, Gazzinelli RT, Antonelli LRDV. Asymptomatic vivax malaria is associated with an IFN-?-program on adaptive immunity. J Transl Med. 2025 Mar 19; 23(1):351.
-
Henriques PM, Almeida GG, Rimkute I, Dos Santos LI, Liechti T, Marino AP, do Vale INPC, Vasconcelos-Santos DV, Martins-Filho OA, Gazzinelli RT, Roederer M, Sher A, Teixeira-Carvalho A, Jankovic D, Antonelli LRDV. Cytotoxic Signature and IFN-? Production Dominate CD4+ T-Cell Response During Human Toxoplasmosis. Immunology. 2025 06; 175(2):151-164.